{"ticker": {"uuid": "2343b247-36a5-4b4e-89e3-a59397cef98f", "symbol": "ORY", "name": "Oryzon Genomics S.A.", "exchange": "MCE", "country": "ES", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Oryzon Genomics S A : announces U.S. patent grant for vafidemstat in borderline personality disorder (BPD)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxQMm9KaTFwYmNnbWtwNWhMZEkyYXRxUExCU0RoRWVkSUtzel9BZk1WeG1nUC1FTjVuU1l3NkhjVnJiTThjWGhLMkRkR2tqdW9JaXEyOEtYNGt1c2ZPMjY0aUdBUERJR0ZGY3VxTHBLVjIwTUk5ck5XMkF3Q2xPdG9XZkRKZ3A4dGFPRm1xMERKekRMaDE4RGNza0N0S3pjb3UwS2lFYUtqSm1xY3VRaHItSFlwbDZITGk3VU9wYTdTNVdzUW84SFo3QUV1YTFTb2RDODZkUzNQNi1peFNCQjlXcnVWZHI?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oryzon Genomics Raises \u20ac12 Million Through Discounted Private Share Placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPXzMxeHpKYzlyR25KNU5JT1hSNmEtcnZCR0otSjFZSzZ3UmoxaFVvUlhvaTc5S2pmcWZVZDdHOHVsclpQMTBrZm9jWnRVbnQwVnpoRXZnNmlnSmtUQkRmczZPQ1A0UmZDRGQ0U2k4UEN2dWQwSkNaNFYxZTBZRk1wUG1nRjg3NlRDcWs3QS1TVW1feGNkd3E0N1FWa0dMajdac1lSMEtLNHczQVcyT1V5UHVvZTc0Y1NYd01nZ29nR0JlZWdxWHJHaA?oc=5", "source_name": "TipRanks", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oryzon raises \u20ac12 million through share placement By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPbVdLWGZ6VkZqaHdQNzZWZnVwUFBSV2dPUUpnRWxzM1hHMWxiUEJtV3NnOTM3N2xKM3VTZ0s5NWdYS0NjZzZpZWJlOTZ1WlQ3ZWlpTHJfaWl6d3IzaEpOUXZueWJqQ3lMNHpWUkV4UFk4RmlnTTVBdWdhdGswSDEyM1YtTTE2aFVnSmNPanNndHdwZVpGNS1fWjE1dG55Q2l1WjR5OVFxVDRVQlRRSXc?oc=5", "source_name": "Investing.com Canada", "published_at": "2026-07-01T13:15:53+00:00", "published_display": "01 Jul 2026 13:15", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oryzon shares fall 11% after launching up to \u20ac10 million share placement By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPY09XZndmUjAxc2JBYllDdEJxcVVQMFViY3pHclhmV20taTdBOHNIekZyNVdQM2lJek83dnh4YTQ4T2dtMjN3YVFTbG5relNoSDczZGlsVUVSYW5zU2MyakxJQnFFWE40WWRWQ0ZBeFRfS29EWHhHUXk1bzdjWjdsTjhLQ2owUkxQR3d6MUhybk9ieDhSajMtYkpqYldoRWViTUlsSUJMWnJxUzl6MWdWRng1cHNSLTZFREJRcFNIeWxUUElI?oc=5", "source_name": "Investing.com India", "published_at": "2026-07-01T09:02:49+00:00", "published_display": "01 Jul 2026 09:02", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Oryzon Genomics stock sliding today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPM1phd2MxYmEtQU03ZHJmM2lIUjJFeUYyeWEwdmplSEJlQ2tPVWdvc0V2V1htTWF5ZEVEUzd0UDhBc2JyLWEtaEEwUDRxWk8xT0tFbDFaRWNxdXJJaHJOODNxU3JEaExma2xMU01LbXdNY19yVHgwcHdzWHloOE9iUEJxSkxUamZ0S2tJQ0JObzNRcUgwcjNMd2lqYmNYc3JzZUhrdGlKUQ?oc=5", "source_name": "Investing.com", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oryzon shares fall 11% after launching up to \u20ac10 million share placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNV1prSkRCRk5ka0tjRTRrRkYxOTgwSzJWUUVVZ0dSUkJNWXZrUmZmOEN4RlRtaWFjT0NoWHZFWHR5aHp0UFA1cEYzdTBDbTBCOXNldVc5S1RUOF9fcmROa2JHQ25IUUpLbTZnd24wVlkxSHRQT01lVkZnbG5QeElqY3Z4SmdrU1lHQnNyeGZsLXd5WEFZSWUxTTJBUW5ZcExmeGNPeVdXRHNpLWRmeWpKTE5ZU21INTllczc2YjRwSEUwRXZUX0E?oc=5", "source_name": "Investing.com", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oryzon Genomics S.A. (BME:ORY) Analysts Just Slashed This Year's Revenue Estimates By 10%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31st, 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQZFJNYVlLUUFGRExVT0s3RXVld2l2RFdxQVdRSFA4YUZPZDBHUlhNa1VGNDF0VmU5MzFrclhiWDg4aTE1VTJYSWJyNWsyYWo2LXRzLUNqbDdtNVh5el9VTzZ1d1h0YXRVRTBOTVFxVEFoWWtfVUZqaWtCblBkcmJ3cXNJVjJNYUE0Y1ZNaGg3WjhXcTRGZ05LZG9BOW1YRW1wTnRtb2s2cTdhdHZwWHBHOA?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oryzon Genomics S.A.: Target Price Consensus and Analysts Recommendations | ORY | ES0167733015", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNUUY5TVBjX0hlQ2p1X2NMR3dDcFJyREhuejZqd2czNS1kMG9aU0EzN3pYNnd1NDZkYjdTVldsNEFBS2RFM0hYUU5jZkpqcWZLYXpteXB0UjBkeEM2R3pvLUpiQUtHSVA4YlFTaFczNDdOdmFOVTNPMFN0SGFMNTA5NXBxWXM5UEtaaEE?oc=5", "source_name": "marketscreener.com", "published_at": "2020-08-18T14:27:57+00:00", "published_display": "18 Aug 2020 14:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Oryzon Genomics S A : announces U.S. patent grant for vafidemstat in borderline personality disorder (BPD)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxQMm9KaTFwYmNnbWtwNWhMZEkyYXRxUExCU0RoRWVkSUtzel9BZk1WeG1nUC1FTjVuU1l3NkhjVnJiTThjWGhLMkRkR2tqdW9JaXEyOEtYNGt1c2ZPMjY0aUdBUERJR0ZGY3VxTHBLVjIwTUk5ck5XMkF3Q2xPdG9XZkRKZ3A4dGFPRm1xMERKekRMaDE4RGNza0N0S3pjb3UwS2lFYUtqSm1xY3VRaHItSFlwbDZITGk3VU9wYTdTNVdzUW84SFo3QUV1YTFTb2RDODZkUzNQNi1peFNCQjlXcnVWZHI?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oryzon Genomics Raises \u20ac12 Million Through Discounted Private Share Placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPXzMxeHpKYzlyR25KNU5JT1hSNmEtcnZCR0otSjFZSzZ3UmoxaFVvUlhvaTc5S2pmcWZVZDdHOHVsclpQMTBrZm9jWnRVbnQwVnpoRXZnNmlnSmtUQkRmczZPQ1A0UmZDRGQ0U2k4UEN2dWQwSkNaNFYxZTBZRk1wUG1nRjg3NlRDcWs3QS1TVW1feGNkd3E0N1FWa0dMajdac1lSMEtLNHczQVcyT1V5UHVvZTc0Y1NYd01nZ29nR0JlZWdxWHJHaA?oc=5", "source_name": "TipRanks", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oryzon raises \u20ac12 million through share placement By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPbVdLWGZ6VkZqaHdQNzZWZnVwUFBSV2dPUUpnRWxzM1hHMWxiUEJtV3NnOTM3N2xKM3VTZ0s5NWdYS0NjZzZpZWJlOTZ1WlQ3ZWlpTHJfaWl6d3IzaEpOUXZueWJqQ3lMNHpWUkV4UFk4RmlnTTVBdWdhdGswSDEyM1YtTTE2aFVnSmNPanNndHdwZVpGNS1fWjE1dG55Q2l1WjR5OVFxVDRVQlRRSXc?oc=5", "source_name": "Investing.com Canada", "published_at": "2026-07-01T13:15:53+00:00", "published_display": "01 Jul 2026 13:15", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oryzon shares fall 11% after launching up to \u20ac10 million share placement By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPY09XZndmUjAxc2JBYllDdEJxcVVQMFViY3pHclhmV20taTdBOHNIekZyNVdQM2lJek83dnh4YTQ4T2dtMjN3YVFTbG5relNoSDczZGlsVUVSYW5zU2MyakxJQnFFWE40WWRWQ0ZBeFRfS29EWHhHUXk1bzdjWjdsTjhLQ2owUkxQR3d6MUhybk9ieDhSajMtYkpqYldoRWViTUlsSUJMWnJxUzl6MWdWRng1cHNSLTZFREJRcFNIeWxUUElI?oc=5", "source_name": "Investing.com India", "published_at": "2026-07-01T09:02:49+00:00", "published_display": "01 Jul 2026 09:02", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Oryzon Genomics stock sliding today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPM1phd2MxYmEtQU03ZHJmM2lIUjJFeUYyeWEwdmplSEJlQ2tPVWdvc0V2V1htTWF5ZEVEUzd0UDhBc2JyLWEtaEEwUDRxWk8xT0tFbDFaRWNxdXJJaHJOODNxU3JEaExma2xMU01LbXdNY19yVHgwcHdzWHloOE9iUEJxSkxUamZ0S2tJQ0JObzNRcUgwcjNMd2lqYmNYc3JzZUhrdGlKUQ?oc=5", "source_name": "Investing.com", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oryzon shares fall 11% after launching up to \u20ac10 million share placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNV1prSkRCRk5ka0tjRTRrRkYxOTgwSzJWUUVVZ0dSUkJNWXZrUmZmOEN4RlRtaWFjT0NoWHZFWHR5aHp0UFA1cEYzdTBDbTBCOXNldVc5S1RUOF9fcmROa2JHQ25IUUpLbTZnd24wVlkxSHRQT01lVkZnbG5QeElqY3Z4SmdrU1lHQnNyeGZsLXd5WEFZSWUxTTJBUW5ZcExmeGNPeVdXRHNpLWRmeWpKTE5ZU21INTllczc2YjRwSEUwRXZUX0E?oc=5", "source_name": "Investing.com", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oryzon Genomics S.A. (BME:ORY) Analysts Just Slashed This Year's Revenue Estimates By 10%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31st, 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQZFJNYVlLUUFGRExVT0s3RXVld2l2RFdxQVdRSFA4YUZPZDBHUlhNa1VGNDF0VmU5MzFrclhiWDg4aTE1VTJYSWJyNWsyYWo2LXRzLUNqbDdtNVh5el9VTzZ1d1h0YXRVRTBOTVFxVEFoWWtfVUZqaWtCblBkcmJ3cXNJVjJNYUE0Y1ZNaGg3WjhXcTRGZ05LZG9BOW1YRW1wTnRtb2s2cTdhdHZwWHBHOA?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oryzon Genomics S.A.: Target Price Consensus and Analysts Recommendations | ORY | ES0167733015", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNUUY5TVBjX0hlQ2p1X2NMR3dDcFJyREhuejZqd2czNS1kMG9aU0EzN3pYNnd1NDZkYjdTVldsNEFBS2RFM0hYUU5jZkpqcWZLYXpteXB0UjBkeEM2R3pvLUpiQUtHSVA4YlFTaFczNDdOdmFOVTNPMFN0SGFMNTA5NXBxWXM5UEtaaEE?oc=5", "source_name": "marketscreener.com", "published_at": "2020-08-18T14:27:57+00:00", "published_display": "18 Aug 2020 14:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 75, "total_relevant": 9, "sentiment_summary": {"positive": 2, "negative": 2, "neutral": 5, "score": 47, "total": 9, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 3.3, "count": 6}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 2.9, "latest_week": "2026-07-17", "one_week_move": 0.9, "four_week_move": -7.5, "twelve_week_move": 4.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.550318, "market_dynamics_buy_signal": false, "relative_strength": -15.255395, "fair_value_gap": 22.3, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 41.4479, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.9% over one week, -7.5% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 52, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "marketscreener.com", "count": 2}, {"label": "Investing.com", "count": 2}, {"label": "TipRanks", "count": 1}, {"label": "Investing.com Canada", "count": 1}, {"label": "Investing.com India", "count": 1}, {"label": "simplywall.st", "count": 1}, {"label": "Market source", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 9}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 6}, {"label": "Earnings", "count": 2}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "47/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "9", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.9% over one week, -7.5% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Oryzon Genomics S A : announces U.S. patent grant for vafidemstat in borderline personality disorder (BPD)"}], "updated_at": "2026-07-21T14:24:25.523169+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}